Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO

التفاصيل البيبلوغرافية
العنوان: Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO
المؤلفون: Agustín C. Martín-García, Xavier Bosch, Oscar Vedia, Emilia Blanco, Javier López-Pais, Óscar Fabregat-Andrés, Aitor Uribarri, Gisela Feltes, Iván J. Núñez-Gil, Sergio Raposeiras-Roubín, Mireia Andrés, Ana Martín-García, Irene Martín-de-Miguel, Miguel Corbí-Pascual, Marta Guillen-Marzo, Alejandro Sánchez-Grande-Flecha, Alessandro Sionis, Manuel Almendro-Delia
المصدر: Medicina Clínica (English Edition). 155:521-528
بيانات النشر: Elsevier BV, 2020.
سنة النشر: 2020
مصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, Malignancy, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Takotsubo Cardiomyopathy, Internal medicine, medicine, Humans, 030212 general & internal medicine, Risk factor, Aged, Heart Failure, business.industry, Cancer, Prognosis, medicine.disease, Hospitalization, Radiation therapy, Heart failure, Cohort, Female, Neoplasm Recurrence, Local, business, Mace
الوصف: Background and objectives A relationship between neoplasms and Takotsubo syndrome (TS) has been postulated. Our goal was to determine its prevalence in patients with TS, compare the clinical profile of TS with or without cancer and study its long-term evolution. Materials and methods The oncological situation of patients included in the National Registry on TAKOtsubo syndrome (RETAKO), admitted between 2002 and 2019, provided by 38 hospitals throughout the country is analysed. Any history of malignancy or tumour, even benign, that received chemotherapy, radiotherapy or specific surgery, current or past, was considered. Results Any type of neoplasm was described in 129 (11.8%), within a cohort of 1097 patients with TS. The cohort of patients with neoplasm, with a lower percentage of women (79.1 vs. 88.3%; p = 0.003), showed a non-significant tendency at an older age, hyperuricaemia, sleep apnoea and lower LVEF on admission, with a similar cardiovascular risk factor profile, but more chronic anaemia and immunosuppression. The most common neoplasm was breast cancer. During their hospital stay, the cancer patients suffered more complications, highlighting heart failure/shock, acute renal failure and a trend towards combined infections. On follow-up, they presented higher mortality and more combined MACE events, with a non-significant trend in the occurrence of cardiovascular recurrences or readmissions. Conclusions The prevalence of neoplasms in patients with TS is high. The clinical presentation is different in relation to patients who do not have neoplasms and they probably represent a risk factor for a worse hospital and long term prognosis.
تدمد: 2387-0206
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48514bb6121ceb79de5a9087d96d719d
https://doi.org/10.1016/j.medcle.2020.01.017
حقوق: CLOSED
رقم الأكسشن: edsair.doi.dedup.....48514bb6121ceb79de5a9087d96d719d
قاعدة البيانات: OpenAIRE